Yixuan Li

Title: Yixuan Li: Innovator in Chemical Drug Development

Introduction

Yixuan Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of chemical drugs, particularly in the development of compounds with anti-diabetic properties. With a total of 4 patents to his name, Li's work is recognized for its innovative approaches and practical applications.

Latest Patents

One of Yixuan Li's latest patents is titled "Compound with α-glucosidase inhibitory activity and application thereof." This invention focuses on a compound that exhibits strong anti-diabetes activity, providing a valuable alternative to existing treatments. The compound, specifically a 5-hydroxymethyl-8-methyl-2-(N-arylamino)-pyrano[2,3-c]pyridine-3-(N-aryl)-formamide series, demonstrates significant application value in the medical field.

Another notable patent is the "Method for modifying gliadin and application thereof." This method involves dissolving gliadin in a solvent and adding a proline endoprotease to create a modified gliadin. The resulting product maintains stability in various conditions, including high temperatures and the presence of sodium chloride, making it suitable for long-term storage and use.

Career Highlights

Yixuan Li is affiliated with China Agricultural University, where he conducts research and development in the field of chemical drugs. His work has garnered attention for its potential impact on diabetes treatment and food science.

Collaborations

Li collaborates with esteemed colleagues, including Pengjie Wang and Fazheng Ren, who contribute to his research endeavors. Their combined expertise enhances the innovative capacity of their projects.

Conclusion

Yixuan Li stands out as a key figure in the realm of chemical drug innovation. His patents reflect a commitment to advancing medical science and improving treatment options for diabetes. Through his work, he continues to make a meaningful impact in his field.